Immunogenicity of purified lipopolysaccharide or protein-oligosaccharide conjugates of Pasteurella multocida type 6:B in mice

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 21, Issue 4, 1998, Pages 257-279

  Muniandy, Narasiman ^a   Love, Daria N ^b   Mukkur, T K S ^c,d  

^a VETERINARY RESEARCH INSTITUTE   (Malaysia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CSIRO   (Australia)

^d Univ of S Queensland   (Australia)

Author keywords

Haemorrhagic septicaemia; Lipopolysaccharide; Mouse protection; Pasteurella multocida type 6:B; Protein oligosaccharide conjugate; Toxicity

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; OLIGOSACCHARIDE; PROTEINASE K;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PASTEURELLA MULTOCIDA; SUBCUTANEOUS DRUG ADMINISTRATION;

ADIPIC ACIDS; AMINATION; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEMOCYANIN; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; O ANTIGENS; OLIGOSACCHARIDES; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; PROTEINS; SERUM ALBUMIN, BOVINE;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; PASTEURELLA MULTOCIDA;

EID: 0031663806     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(98)00015-0     Document Type: Article

References (47)

1. Namioka S., Murata M. Serological studies on Pasteurella multocida. I. A simplified method for capsule typing of the organism. Cornell Vet. 51:1961;498-507.
2. Carter G.R. Proposed modification of the serological classification of Pasteurella multocida. Vet Rec. 75:1963;1264.
3. Bain RVS, De Alwis MCL, Carter GR, Gupta BK. Haemorrhagic septicemia. FAO Animal production and Health Paper; No. 33. Rome: Food and Agriculture Organisation of the United Nations, 1982.
4. Chandrasekaran S., Kennett L., Yeap P.C., Muniandy N., Rani B., Mukkur T.K.S. Characterization of immune response and duration of protection in buffaloes immunised with haemorrhagic septicaemia vaccines. Vet Microbiol. 41:1994;213-219.
5. Interior MM. Country report - Philippines. In: Pasteurellosis in production animals. ACIAR Proceedings, No. 43, 1993. pp. 254-256.
6. Neramitmansook P. Country report - Thailand. In: Pasteurellosis in production animals. ACIAR Proceedings, No. 43, 1993. pp. 234-237.
7. Chandrasekaran S., Kennett L., Yeap P.C., Muniandy N., Rani B., Mukkur T.K.S. Relationship between active protection in vaccinated buffaloes against haemorrhagic septicaemia and passive mouse protection test or serum antibody titres. Vet Microbiol. 41:1994;303-309.
8. Bain R.V.S., Knox K.W. The antigens of Pasteurella multocida Type 1. II. Lipopolysaccharides. Immunology. 4:1961;122-129.
9. Rebers P.A., Heddleston K.L., Rhoades K.R. Isolation from Pasteurella multocida of a lipopolysaccharide antigen with immunizing and toxic properties. J Bact. 93:1967;7-14.
10. Ramdani, Adler B. Opsonic monoclonal antibodies against lipopolysaccharide (LPS) antigens of Pasteurella multocida and the role of LPS in immunity. Vet Microbiol. 26:1991;335-347.
11. Poxton IR, Wijewardana T, Abdullah MZ, Gilmour NJL, The cell surface antigens of Pasteurella multocida, definition of a protective antigen in type A strains. Proceedings of the Fourth International Workshop on Haemorrhagic Septicaemia. Kandy, Sri Lanka, 1991. pp. 58-64.
12. Heddleston K.L., Rebers P.A., Ritchie A.E. Immunizing and toxic properties of particulate antigens from two immunogenic types of Pasteurella multocida of avian origin. J Immunol. 96:1966;124-133.
13. Rebers P.A., Heddleston K.L. Immunologic comparison of Westphal-type lipopolysaccharides and free endotoxins from an encapsulated and a nonencapsulated avian strain of Pasteurella multocida. Am J Vet Res. 35:1974;555-560.
14. Ganfield D.J., Rebers P.A., Heddleston K.L. Immunogenic and toxic properties of a purified lipopolysaccharide-protein complex from Pasteurella multocida. Infect Immun. 14:1976;990-999.
15. Rebers P.A., Phillips M., Rimler R., Boykins R.A., Rhoades K.R. Immunizing properties of Westphal lipopolysaccharide from an avian strain of Pasteurella multocida. Am J Vet Res. 41:1980;1650-1654.
16. Wijewardana T.G., Wilson C.F., Gilmour N.J.L., Poxton I.R. Production of mouse monoclonal antibodies to Pasteurella multocida type A. and the immunological properties of a protective anti-lipopolysaccharide antibody. J Med Microbiol. 33:1990;217-222.
17. Philips M., Rimler R.B. Protection of chickens by ribosomal vaccine from Pasteurella multocida: Dependence on homologous lipopolysaccharide. Am J Vet Res. 45:1984;1785-1789.
18. Svenson S.B., Lindberg A.A. Coupling of acid labile salmonella specific oligosaccharides to macromolecular carriers. J Immunol Methods. 25:1979;323-335.
19. Lambden P.R., Heckels J.E. Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolysaccharide of Neisseria gonorrhoea P9. J Immunol Methods. 48:1982;233-240.
20. Tsay G.C., Collins M.S. Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immuno type 1 in mice. Infect Immun. 45:1984;217-221.
21. Kabir S. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae. J Med Microbiol. 23:1987;9-18.
22. Cryz S.J, Lang A.B., Sadoff J.C., Germanier R., Furer E. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates. Infect Immun. 55:1987;1547-1551.
23. Westphal O, Jann K. Bacterial Lipopolysaccharides. Extraction with phenol-water and further applications of this procedure. In: Whistler RL, editor. Methods in carbohydrate chemistry, Vol. 5. New York: Academic Press, 1965. pp. 83-91.
24. Jacques I., Dubray G. Escherichia hermannii (ATCC 33651) polysaccharide-protein conjugates: comparison of two conjugation methods for the induction of humoral responses in mice. Vaccine. 9:1991;559-563.
25. Jennings H.J., Lugowski C. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol. 127:1981;1011-1018.
26. Cryz S.J. Jr., Furer E., Sadoff J.C., Germanier R. Pseudomonas aeurginosa immunotype 5 polysaccharide-Toxin A conjugate vaccine. Infect Immun. 52:1986;161-165.
27. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 28:1956;350-356.
28. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 87:1978;206-210.
29. Snipes K.P., Hansen L.M., Hirsh D.C. Plasma- and iron-regulated expression of high molecular weight outer membrane proteins by Pasteurella multocida. Am J Vet Res. 49:1988;1336-1338.
30. Hitchcock P.J., Brown T.M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol. 154:1983;269-277.
31. 4. Nature (London). 227:1970;680-685.
32. Tsai C.M., Frasch C.E. A sensitive silver strain for detecting lipopolysaccharide in polyacrylamide gels. Anal Biochem. 119:1982;115-119.
33. Hermans J., Vaerman J.P. Clin Chim Acta. 3:1958;430-434. Cited in: Immunodiffusion. Crowle AJ, editor. Academic Press, 1961.
34. Towbin H., Stachelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc Natl Acad Sci USA. 76:1979;4350-4354.
35. Mukkur T.K.S. Immunizing efficacy of aromatic-dependent Salmonella dublin in mice and calves. Comp Immunol Microbiol Infect Dis. 14:1991;243-256.
36. Karkhanis Y.D., Zeltner J.Y., Jackson J.J., Carlo D.J. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem. 85:1978;595-601.
37. Goldman R.C., Leive L. Heterogeneity of antigenic sidechain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2. Eur J Biochem. 107:1980;145-153.
38. Palva E.T., Makela P.H. Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodiumdodecyl sulfate polyacrylamide gel electrophoresis. Eur J BioChem. 107:1980;137-143.
39. Lugtenberg B., Boxtel R., Jong M. Atrophic rhinitis in swine: Correlation of Pasteurella multocida pathogenicity with membrane protein and lipopolysaccharide patterns. Infect Immun. 46:1984;48-54.
40. Rimler R.B. Comparisons of Pasteurella multocida lipopolysaccharides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine relationship between group B and E hemorrhagic septicaemia strains and serologically related group A strains. J Clin Microbiol. 28:1990;654-659.
41. Schmeer M.J.F., Rebers P.A. Studies of immunogenicity of Westphal lipopolysaccharides from Pasterella multocida in mice. J Comp Path. 89:1979;531-539.
42. Sandlin R., Stein D.C. Structural heterogeneity of lipopolysaccharides of Neisseriaceae. FEMS Microbiol Lett. 90:1991;69-72.
43. Wiel P.A., Witvliet M.H., Evenberg D., Derks H.J.G.M., Beuvery E.C. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide. Vaccines. 5:1987;33-38.
44. Jann B., Reske K., Jann K. Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Eur J Biochem. 60:1975;239-246.
45. Mukkur T.K.S. Immunogenicity of a chaotropically extracted protective antigen of Pasteurella multocida type A (bovine origin) against experimental pasteurellosis in mice. J Gen Microbiol. 113:1979;37-43.
46. Mukkur T.K.S., Pyliotis N.A. The potassium thiocyanate extract of Pasteurella multocida: Electron microscopy and susceptibility of its immunogenic activity to some physical, chemical and enzymatic treatments. J Comp Path. 91:1981;427-437.
47. Lu Y.S., Aguila H.N., Lai W.C., Pakes S.P. Antibodies to outer membrane proteins but not lipopolysaccharide inhibit pulmonary proliferation of Pasterella multocida in mice. Infect Immun. 59:1991;48-54.